Glycemic ControlSleeve gastrectomy

Clinical evidence dossier

Sleeve gastrectomy

Fasting Plasma Glucose (FPG)

Evidence signal

Evidence signal

Strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
4
Supporting studies available for review
4
Randomized trials
4
Reported effects
7

Clinical conclusion

Sleeve gastrectomy shows a strong positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.

Observed effects

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
0

Consistency

Consistency classification

Consistent

Positive
3
No effect
1
Mixed
0
Negative
0

Population and applicability

Structured population data were available for 4 of 4 supporting studies. 4 studies described participants with type 2 diabetes. 2 studies described adult participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Obese patients diagnosed with type 2 diabetes.
  • Patients considering bariatric surgery as a treatment option.
  • Adults diagnosed with Type 2 diabetes.
  • Individuals seeking weight loss through medical or surgical interventions.
  • Obese individuals aged 18-65 with type 2 diabetes.
  • Patients who have not achieved glycemic control through lifestyle changes.
  • Adults with obesity and type 2 diabetes.
  • Patients considering bariatric surgery for weight management.

Limitations

  • 1 supporting study does not have a displayable topic-matched quantitative effect.
  • Evidence uses heterogeneous comparison contexts: active_comparator, baseline_within_group, usual_care.
  • 2 of 4 studies with duration data have follow-up of 12 weeks or less.
  • 1 study contains conflicting p-value and significance fields; those significance claims are suppressed.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence